Mitral Valve Replacement for Mitral Stenosis Secondary to Massive Mitral Annular Calcium

Minseob Jeong1, William C Roberts2

  • 1Baylor Scott & White Heart and Vascular Institute, Baylor University Medical Center, Baylor Scott & White Health, Dallas, Texas.

Insights

Massive mitral annular calcium (MAC) can cause mitral stenosis (MS). Mitral valve replacement in these cases carries a high risk, with 6 of 11 patients dying postoperatively.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Valvular Heart Disease

Background:

  • Mitral annular calcium (MAC) is a common finding in elderly populations.
  • Massive MAC can obstruct mitral valve inflow, leading to mitral stenosis (MS).
  • The surgical risks associated with mitral valve replacement (MVR) in massive MAC are not well-defined.

Purpose of the Study:

  • To highlight the potential hazards of mitral valve replacement in patients with mitral stenosis secondary to massive mitral annular calcium.
  • To describe the clinical outcomes and valve morphology in patients undergoing MVR for massive MAC.

Main Methods:

  • Retrospective review of clinical data and operative findings.
  • Analysis of 11 patients who underwent mitral valve replacement for mitral stenosis secondary to massive MAC.
  • Morphological assessment of excised mitral valves.

Main Results:

  • Six out of 11 patients (54.5%) died postoperatively.
  • Five of the deceased patients had severe (4+/4+) MAC.
  • Massive MAC was characterized by extensive calcification of the posterior mitral leaflet extending to the anterior leaflet.

Conclusions:

  • Mitral valve replacement in patients with mitral stenosis secondary to massive MAC is associated with high operative mortality.
  • Careful consideration and risk stratification are crucial before proceeding with MVR in these complex cases.
  • The extent of MAC, particularly severe calcification, is a significant predictor of poor outcomes.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
16
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
25
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
29
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
24
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
36
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
28